Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Vanguard Total Bond Market Index Fund ETF (BND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Vanguard Total Bond Market Index Fund ETF — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $288 (market cap $39.89B), while Vanguard Total Bond Market Index Fund ETF trades at $72.47. Which is the better fit depends on your goals.
| ALNY | BND | |
|---|---|---|
Market Cap | $39.89B | — |
Sector | Health | — |
52-Week High | $491.22 | $75.17 |
52-Week Low | $278.09 | $72.45 |
Enterprise Value | $38.15B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
BND trades at $72.77, down 0.08% on the day, with a bearish technical signal driven by moving averages. Recent news highlights its role as a core bond ETF for stability and income, with comparisons to peers like iShares IGIB focusing on yield and cost advantages. The fund's dividend history shows consistent payouts, supporting its appeal for income-focused investors amid market volatility.
The outlook for BND is cautious due to bearish technicals and interest rate risks, but its low-cost, diversified bond exposure offers defensive appeal. Key risks include duration sensitivity to Fed hikes, while institutional inflows signal confidence in fixed income. Investors should weigh yield stability against potential price declines if rates rise further.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Vanguard Total Bond Market Index Fund ETF
This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.
Read more on BND →
